Please note: In October and November 2010, the MHRA moved from its Market Towers address to a new location on Buckingham Palace Road. Please go to the contact us section of the website for updated contact details.
In this Issue
Drug safety advice
- Varenicline: suicidal thoughts and behaviour
- Bisphosphonates: atrial fibrillation
Yellow Card scheme update
- Black triangle: symbol for intensively monitored drugs or vaccines
Hot topic
- Inhaled products that contain corticosteroids
Stop Press
- Rotigotine patches: new prescribing and storage requirements
- Enoxaparin (Clexane) contamination: latest information
- Ergot-derived dopamine agonists: new warnings and contraindications
- Etoricoxib: new prescribing guidelines
- Recombinant human erythropoietins: new warning for use in patients with cancer
Other information from the MHRA
- Patient Information Leaflet of the Month: Aldactone
- New section on MHRA website for ophthalmologists and cardiologists
Drug Safety Update: Volume 1, Issue 12 July 2008 
